A detailed history of Sanders Morris Harris LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Sanders Morris Harris LLC holds 559,500 shares of PGEN stock, worth $587,475. This represents 0.15% of its overall portfolio holdings.

Number of Shares
559,500
Previous 705,000 20.64%
Holding current value
$587,475
Previous $1.02 Million 13.5%
% of portfolio
0.15%
Previous 0.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$1.27 - $1.75 $184,785 - $254,625
-145,500 Reduced 20.64%
559,500 $884,000
Q1 2024

Apr 11, 2024

BUY
$1.21 - $1.75 $853,050 - $1.23 Million
705,000 New
705,000 $1.02 Million
Q3 2023

Oct 05, 2023

BUY
$1.08 - $1.85 $91,800 - $157,250
85,000 Added 26.15%
410,000 $582,000
Q2 2023

Jul 10, 2023

BUY
$0.96 - $1.4 $67,200 - $98,000
70,000 Added 27.45%
325,000 $373,000
Q1 2023

Apr 07, 2023

BUY
$0.88 - $2.19 $145,200 - $361,350
165,000 Added 183.33%
255,000 $270,000
Q2 2022

Jul 11, 2022

BUY
$1.15 - $2.53 $11,500 - $25,299
10,000 Added 12.5%
90,000 $121,000
Q1 2022

Apr 11, 2022

BUY
$1.91 - $3.98 $76,400 - $159,200
40,000 Added 100.0%
80,000 $169,000
Q4 2021

Feb 02, 2022

SELL
$3.53 - $5.5 $17,650 - $27,500
-5,000 Reduced 11.11%
40,000 $148,000
Q3 2021

Oct 13, 2021

BUY
$4.99 - $6.55 $49,900 - $65,500
10,000 Added 28.57%
45,000 $225,000
Q1 2021

Apr 19, 2021

BUY
$6.74 - $10.95 $235,900 - $383,250
35,000 New
35,000 $241,000
Q1 2021

Apr 14, 2021

SELL
$6.74 - $10.95 $269,600 - $438,000
-40,000 Closed
0 $0
Q4 2020

Jan 26, 2021

SELL
$3.75 - $10.56 $378,033 - $1.06 Million
-100,809 Reduced 71.59%
40,000 $408,000
Q3 2020

Oct 16, 2020

BUY
$3.5 - $6.2 $492,831 - $873,015
140,809 New
140,809 $493,000
Q2 2020

Jul 09, 2020

SELL
$2.16 - $5.46 $239,347 - $605,017
-110,809 Closed
0 $0
Q1 2020

Apr 09, 2020

BUY
$1.46 - $7.19 $161,781 - $796,716
110,809 New
110,809 $0

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $219M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Sanders Morris Harris LLC Portfolio

Follow Sanders Morris Harris LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Morris Harris LLC with notifications on news.